In our study, amplification of chromosome 17, in which ERBB2 is located, was very common in HER2-positive tumors, which established the unique biological property of HER2-positive breast cancer and no particular CNVs enriched in HER2-low breast cancer were identified. Here, ERBB2 is linked to breast cancer.